Cargando…
Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer
Numerous years of cell line-based studies have enhanced the current understanding of cancer and its treatment. However, limited success has been achieved in treating hormone receptor-positive, HER2-negative metastatic breast cancers that are refractory to treatment. The majority of cancer cell lines...
Autores principales: | Butti, Ramesh, Kapse, Prachi, Bhadauriya, Garima, Ahmad, Suhail, Chaubal, Rohan, Parab, Pallavi, Kadam, Rasika, Mahapatra, Soumya S., Shet, Tanuja, Dutt, Amit, Gupta, Sudeep, Kundu, Gopal C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091080/ https://www.ncbi.nlm.nih.gov/pubmed/36999625 http://dx.doi.org/10.3892/or.2023.8536 |
Ejemplares similares
-
CRISPR based therapeutics: a new paradigm in cancer precision medicine
por: Das, Sumit, et al.
Publicado: (2022) -
Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
por: Jäger, Wolfgang, et al.
Publicado: (2014) -
Development and characterization of a human orthotopic neuroblastoma xenograft
por: Stewart, Elizabeth, et al.
Publicado: (2015) -
Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors
por: Stewart, Elizabeth, et al.
Publicado: (2017) -
Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma †
por: Hoffman, Robert M.
Publicado: (2017)